Tanya Lewis
Direktor/Vorstandsmitglied bei DIAMEDICA THERAPEUTICS INC.
Vermögen: 832 052 $ am 30.04.2024
Aktive Positionen von Tanya Lewis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DIAMEDICA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.03.2023 | - |
Independent Dir/Board Member | 01.03.2023 | - |
Karriereverlauf von Tanya Lewis
Ehemalige bekannte Positionen von Tanya Lewis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REPLIMUNE GROUP, INC. | Corporate Officer/Principal | 10.05.2021 | 01.04.2024 |
REPLIMUNE GROUP, INC. | Direktor/Vorstandsmitglied | 02.11.2020 | 07.05.2021 |
SYROS PHARMACEUTICALS, INC. | General Counsel | 01.01.2017 | 01.07.2018 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | General Counsel | 30.11.2015 | 01.12.2016 |
TESARO INC | General Counsel | 01.01.2011 | 01.01.2015 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | General Counsel | 01.06.2008 | 01.06.2008 |
KARYOPHARM THERAPEUTICS INC. | General Counsel | 01.10.2018 | - |
Seaside Therapeutics LLC
Seaside Therapeutics LLC Medical DistributorsDistribution Services Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA. | General Counsel | 14.07.2010 | - |
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Tanya Lewis
Northeastern University | Undergraduate Degree |
Massachusetts College of Pharmacy & Health Science | Graduate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Operativ
General Counsel | 7 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
REPLIMUNE GROUP, INC. | Health Technology |
SYROS PHARMACEUTICALS, INC. | Health Technology |
DIAMEDICA THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Seaside Therapeutics LLC
Seaside Therapeutics LLC Medical DistributorsDistribution Services Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA. | Distribution Services |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Börse
- Insiders
- Tanya Lewis
- Erfahrung